+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Acute Kidney Injury (AKI) Disease Treatment Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Acute Kidney Injury (AKI) Disease Treatment Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 142 Pages
  • Global
From
Complement 3 Glomerulopathy (C3G) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Complement 3 Glomerulopathy (C3G) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 69 Pages
  • Global
From
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 49 Pages
  • Global
From
Nephrotic Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Nephrotic Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 143 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Liver Cirrhosis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Liver Cirrhosis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 69 Pages
  • Global
From
Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 95 Pages
  • Global
From
Polycystic Kidney Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic Kidney Diseases - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • October 2024
  • 160 Pages
  • Global
From
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 193 Pages
  • Global
From
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • September 2024
  • 80 Pages
  • Global
From
IgA Nephropathy Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

IgA Nephropathy Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 150 Pages
  • Global
From
Complement 3 Glomerulopathy Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Complement 3 Glomerulopathy Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 105 Pages
  • Global
From
Complement 3 Glomerulopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Idiopathic Membranous Nephropathy Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Idiopathic Membranous Nephropathy Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • August 2024
  • 138 Pages
  • Global
From
Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 60 Pages
  • Global
From
Liver Disease Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Liver Disease Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more